QTTB Q1 2023 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+267.5% YoY

Gross Profit

$3M95.7% margin

Operating Income

-$7M-250.2% margin

Net Income

-$7M-232.0% margin

EPS (Diluted)

$-9.00

QoQ Revenue Growth

+267.5%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$296,000

Balance Sheet

Total Assets

$198M

Total Liabilities

$46M

Stockholders' Equity

$152M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$802,000	+267.5%
Gross Profit	$3M	$257,000	+997.3%
Operating Income	-$7M	-$38M	+80.4%
Net Income	-$7M	$92M	-107.4%